title: [Effect of yifei jianpi recipe on inflammatory cells, levels of interleukin-8 and tumor necrosis factor-alpha in sputum from patients with chronic obstructive pulmonary disease].
abstract: OBJECTIVE
  To explore the effect and the mechanism of yifei jianpi recipe (YFJPR) on patients with chronic obstructive pulmonary disease (COPD).
  
  
  METHODS
  Forty patients with COPD in stable phase were randomly divided into two groups, the treated group and the control group. Indexes including the total and differential count of inflammatory cell in sputum, levels of interleukin-8 (IL-8) and tumor necrosis factor-alpha (TNF-alpha), as well as the percentage of forced expiratory volume in one second in its predicted value (FEV1%) and ratio of FEV1/forced vital capacity (FVC) in patients were measured before and after treatment, and compared with those in 20 healthy subjects.
  
  
  RESULTS
  All the indexes measured in patients before and after treatment were significantly different from those in healthy subjects (P < 0.01). Differential count of polymorphonuclear neutrophil (PMN) and levels of IL-8 and TNF-alpha in sputum in the treated group significantly decreased after treatment (P < 0.01), while the non-PMN differential count and levels of FEV1% and FEV1/FVC significantly increased (P < 0.01). But in the control group, changes only showed in increasing of FEV1% and FEV1/FVC (P < 0.05 or P < 0.01). And the effects in the treated group were better than those in the control group (P < 0.01).
  
  
  CONCLUSIONS
  YFJPR can play a therapeutic role on patients with COPD by way of reducing the airway inflammatory reaction.
authors.affiliation: Respiratory Department, the First Affiliated Hospital to Anhui College of TCM, Hefei 230031. jhy-1227@163.com
authors.forename: Sheng
authors.initials: S
authors.lastname: Wang
authors.forename: Hong-yan
authors.initials: HY
authors.lastname: Ji
authors.forename: Nian-zhi
authors.initials: NZ
authors.lastname: Zhang
authors.forename: Xiu-zhen
authors.initials: XZ
authors.lastname: Zhuo
authors.forename: Li-ping
authors.initials: LP
authors.lastname: Zhao
authors.forename: Hui-zhi
authors.initials: HZ
authors.lastname: Zhu
authors.forename: Wei
authors.initials: W
authors.lastname: Chen
authors.forename: Wei
authors.initials: W
authors.lastname: Ren
mesh_terms: D000328:Adult; D000368:Aged; D004365:Drugs, Chinese Herbal / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D016209:Interleukin-8 / Q000378:metabolism*; D007958:Leukocyte Count; D008297:Male; D008875:Middle Aged; D009504:Neutrophils / Q000473:pathology; D008517:Phytotherapy; D029424:Pulmonary Disease, Chronic Obstructive / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology; D012129:Respiratory Function Tests; D013183:Sputum / Q000166:cytology / Q000378:metabolism; D014409:Tumor Necrosis Factor-alpha / Q000378:metabolism*
chemical_list: D004365:Drugs, Chinese Herbal; D016209:Interleukin-8; D014409:Tumor Necrosis Factor-alpha